Inotuzumab ozogamicin

CD22-directed Immunoconjugate



Inotuzumab ozogamicin Injection

inotuzumab ozogamicin 0.9 MG InjectionGeneric
inotuzumab ozogamicin 0.9 MG Injection [Besponsa]Generic

Inotuzumab ozogamicin desired effects:

  • Decreased DNA Integrity
  • Increased Cellular Death

Inotuzumab ozogamicin drug classes:

  • CD22-directed Immunoconjugate

Inotuzumab ozogamicin pharmacologic actions:

  • Antineoplastic Agents, Immunological
  • Antibiotics, Antineoplastic

Inotuzumab ozogamicin mechanism of action:

  • CD22-directed Antibody Interactions
  • treatable

The content offered on is intended for informational purposes only and not as medical advice. For medical advice you should consult an appropriately licensed and qualified medical professional. If you are experiencing acute or distressing symptoms or life threatening symptoms you should immediately call 911 and/or go to the nearest emergency medical facility.

LegitScript approved
Copyright © Treatable 2023
Last updated: 2/2/2024, 5:50:31 AM